Fig. 2
From: The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
Combination versus sequencing - Proportion of audience who considered combination or sequential therapy more useful. Audience response before and after debate
Fig. 2 | Journal for ImmunoTherapy of Cancer
